The company wants to pay homage to this heritage in psychiatry.

Today , the company wants to pay homage to this heritage in psychiatry, the well-being to and and present their future developments in the treatment of diseases of the central nervous system. Now more than ever, is Janssen-Cilag goal and ultimate goal to satisfy unmet medical needs and ensure the well-being of patients and their families.

However, much more needs to be done in the field of mental health. Each patient is different and there is no drug or treatment that fits all, therefore, the need for further advanced research and development in order not only to new drugs, but also create customized treatment for patients in the future.Alliston K. Reeves Family Professor of Psychology at the Wofford College at Spartanburg, and currently serves as the company president for Quantitative Analyses of behavior.

About authors – being John W. Emeritus Professor of Psychology at Wofford College Spartanburg, which this study has been completed.

Other entries from category "prevention":

Tag Cloud